EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices, announced that its subsidiary closed a successful $8 million equity investment funding round led by a multibillion dollar healthcare company.

EMED Technologies is an industry leader in the design, manufacture, and distribution of cutting-edge medical devices. Our core mission is to empower patient independence by developing patient-centric systems that improve quality of life and are designed for mid to large volume subcutaneous infusions. Since 1991 EMED Technologies has worked with patients, clinicians, and pharmaceutical companies to design, manufacture, distribute, and commercialize innovative drug delivery systems. EMED has consistently pushed the boundaries of medical technology, providing solutions that enhance patient safety, improve clinical outcomes, and simplify drug administration for both patients and healthcare professionals.